Stay updated on Flotetuzumab in Relapsed AML/MDS Post Allo-HCT Clinical Trial
Sign up to get notified when there's something new on the Flotetuzumab in Relapsed AML/MDS Post Allo-HCT Clinical Trial page.
Latest updates to the Flotetuzumab in Relapsed AML/MDS Post Allo-HCT Clinical Trial page
- Check2 days agoChange DetectedThe website has updated the 'type of intervention' feature from version 2.13.3 to 2.14.0, indicating a significant change in this functionality.SummaryDifference1.0%
- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedThe website has been updated from version v2.13.2 to v2.13.3.SummaryDifference0.3%
- Check39 days agoChange DetectedThe website has posted new results (Revision: v2.13.2) on December 6, 2024, following the deletion of the previous results submitted (Revision: v2.12.2) on September 19, 2024.SummaryDifference1%
- Check53 days agoChange DetectedThe website has added new features for downloading study data in various formats, while several key government health-related URLs have been removed.SummaryDifference14%
- Check68 days agoChange DetectedThe website has been updated to version 2.12.2, adding new features for submitting results and downloading data in various formats, while removing the 'No Results Posted' message from the previous version.SummaryDifference17%
- Check75 days agoChange DetectedThe website has been updated from version 2.12.0 to 2.12.1.SummaryDifference0.3%
Stay in the know with updates to Flotetuzumab in Relapsed AML/MDS Post Allo-HCT Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Flotetuzumab in Relapsed AML/MDS Post Allo-HCT Clinical Trial page.